Hereditary angioedema with normal C1 inhibitor: Four types and counting - 07/03/18
Doi : 10.1016/j.jaci.2018.01.015
Bruce L. Zuraw, MD ⁎ 
Division of Rheumatology, Allergy and Immunology, Department of Medicine, University of California San Diego and San Diego VA Healthcare, La Jolla, Calif
∗Corresponding author: Bruce L. Zuraw, MD, 9500 Gilman Dr, Mailcode 0732, La Jolla, CA 92093.9500 Gilman DrMailcode 0732La JollaCA92093
Key words : Hereditary angioedema with normal C1 inhibitor, angiopoietin 1, Factor XII, plasminogen, bradykinin
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: B. L. Zuraw has a patent submitted by both himself and his institution; received royalties from UpToDate; received board membership from US HAEA and MAB; and received consultancy fees from Shire, CSL Behring, Biocryst, and Adverum, and his institution received a grant from the US Hereditary Angioedema Association for other works. |
© 2018
Publié par Elsevier Masson SAS.
Vol 141 - N° 3
P. 884-885 - mars 2018 Retour au numéro
Article précédent
- Long-term benefits of optimal asthma control in pregnancy
- Diane R. Gold, Augusto A. Litonjua
- Maternal asthma severity and control during pregnancy and risk of offspring asthma
- Xiaoqin Liu, Esben Agerbo, Vivi Schlünssen, Rosalind J. Wright, Jiong Li, Trine Munk-Olsen
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?